The explanation for this finding may lie, on the one hand, in the known resistance of patients with cirrhosis to the action of TM22 and, on the other hand, in the inhibitory activity of the PN-1/TM complex on thrombin, which is notably enhanced when the two act together, compared with acting individually.9 Here, SERPINE2 is linked to Cirrhosis.